KPTI

Karyopharm Therapeutics Inc

Jun 24 • 04:00PM ET

9.12

-0.53 -5.49 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: OABI CAMP CNTX HUMA RNA TENX TNXP UNCY WHWK MIST

| Held by: VTI VXF IWC PRFZ QQQS TMED BTEC CHNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-15.09	Insider Own	13.55%	Shs Outstand	22.54M	Perf Week	0.22%
Market Cap	206.69M	Forward P/E	-	EPS next Y	-3.12	Insider Trans	-0.88%	Shs Float	19.59M	Perf Month	11.76%
Enterprise Value	346.71M	PEG	-	EPS next Q	-1.31	Inst Own	77.12%	Short Float	27.30%	Perf Quarter	67.65%
Income	-194.97M	P/S	1.37	EPS this Y	77.24%	Inst Trans	8.95%	Short Ratio	9.91	Perf Half Y	31.41%
Sales	151.12M	P/B	-	EPS next Y	23.53%	ROA	-150.48%	Short Interest	5.35M	Perf YTD	23.91%
Book/sh	-11.78	P/C	2.28	EPS next 5Y	55.85%	ROE	-	52W High	10.99 -17.02%	Perf Year	96.13%
Cash/sh	4.01	P/FCF	-	EPS past 3/5Y	16.03% 15.19%	ROIC	-	52W Low	3.65 149.84%	Perf 3Y	-69.45%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.39% 6.21%	Gross Margin	95.88%	Volatility	8.90% 8.54%	Perf 5Y	-94.38%
Dividend TTM	-	EV/Sales	2.29	EPS Y/Y TTM	-102.63%	Oper. Margin	-55.73%	ATR (14)	0.74	Perf 10Y	-91.91%
Dividend Ex-Date	-	Quick Ratio	1.05	Sales Y/Y TTM	6.33%	Profit Margin	-129.02%	RSI (14)	51.55	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	1.08	EPS Q/Q	55.38%	SMA20	-0.39%	Beta	0.81	Target Price	15.00
Payout	-	Debt/Eq	-	Sales Q/Q	16.83%	SMA50	3.32%	Rel Volume	0.43	Prev Close	9.65
Employees	228	LT Debt/Eq	-	Earnings	May 14 BMO	SMA200	24.70%	Avg Volume	539.86K	Price	9.12
IPO	Nov 06, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.50% 11.68%	Trades		Volume	351,859	Change	-5.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)